In previous studies, a proportion of prostate, bladder, gastric, hepatocellular, and ovarian cancers showed sensitivity to TGFβ1 and their growth was inhibited by stimulation with TGFβ1 [18- 22]. This evidence concerns the gene TGFB1 and ovarian cancer.